GM1 antibodies in post-polio syndrome and previous paralytic polio

Journal of Neuroimmunology

Volumn 139, Issue 1-2, 2003, Pages 141-144

  Farbu, E ^a   Rekand, T ^a   Tysnes, O B ^a   Aarli, J A ^a   Gilhus, N E ^a   Vedeler, C A ^a  

^a HAUKELAND UNIVERSITY HOSPITAL   (Norway)

Author keywords

GM1 antibodies; Immunology; Motor neuron disorder; Post polio syndrome

Indexed keywords

GANGLIOSIDE ANTIBODY; GANGLIOSIDE GM1; IMMUNOGLOBULIN A ANTIBODY; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN M ANTIBODY;

ADULT; AGED; AMYOTROPHIC LATERAL SCLEROSIS; ANTIBODY DETECTION; ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE ASSOCIATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GUILLAIN BARRE SYNDROME; HUMAN; MAJOR CLINICAL STUDY; MALE; MOTOR NEURON DISEASE; NEUROIMMUNOLOGY; POSTPOLIOMYELITIS SYNDROME; PRIORITY JOURNAL;

EID: 0037870345     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-5728(03)00123-1     Document Type: Article

References (11)

1. Bech E., Orntoft T.F., Andersen L.P., Skinhoj P., Jakobsen J. IgM anti-GM1 antibodies in the Guillain-Barré syndrome: a serological predictor of the clinical course. J. Neuroimmunol. 72:1997;59-66.
2. Dalakas M.C. The post-polio syndrome as an evolved clinical entity. Definition and clinical description. Ann. N. Y. Acad. Sci. 753:1995;68-80.
3. Gonzalez H., Khademi M., Andersson M., Wallstrom E., Borg K., Olsson T. Prior poliomyelitis - evidence of cytokine production in the central nervous system. J. Neurol. Sci. 205:2002;9-13.
4. Grimby G., Stalberg E., Sandberg A., Stibrant S.K. An 8-year longitudinal study of muscle strength, muscle fiber size, and dynamic electromyogram in individuals with late polio. Muscle Nerve. 21:1998;1428-1437.
5. Illa I., Leon-Monzon M., Agboatwalla M., Ilyas A., Latov N., Dalakas M.C. Antiganglioside antibodies in patients with acute polio and post-polio syndrome. Ann. N. Y. Acad. Sci. 753:1995;374-377.
6. Isoardo G., Ferrero B., Barbero P., Cucci A., Oggero A., Pipieri A., Ricci A., Verdun E., Bergamasco B., Durelli L. Anti-GM1 and anti-sulfatide antibodies in polyneuropathies. Threshold titers and accuracy. Acta Neurol. Scand. 103(3):2001;180-187.
7. McComas A.J., Quartly C., Griggs R.C. Early and late losses of motor units after poliomyelitis. Brain. 120:1997;1415-1421.
8. Miller D.C. Post-polio syndrome spinal cord pathology. Case report with immunopathology. Ann. N. Y. Acad. Sci. 753:1995;186-193.
9. Pestronk A., Adams R.N., Clawson L., Cornblath D., Kuncl R.W., Griffin D., Drachman D.B. Serun antibodies to GM1 ganglioside in amyotrophic lateral sclerosis. Neurology. 38:1988;1457-1461.
10. Pezeshkpour G.H., Dalakas M.C. Pathology of spinal cord in post-poliomyelitis muscular atrophy. Birth Defects Orig. Artic. Ser. 23:1987;229-236.
11. Van Schaik I.N., Bossuyt P.M.M., Brand A., Vermeulen M. Diagnostic value of GM1 antibodies in motor neuron disorders and neuropathies: a meta-analysis. Neurology. 45:1995;1570-1577.